Approval · Notice of Compliance 20071 · 2017
IOPIDINE: Notice of Compliance 20071
Issued November 22, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20071
- Date
- November 22, 2017
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Transfer of drug identification numbers
Products in this notice
Medicinal ingredients
- APRACLONIDINE HCL 0.5 PER
- APRACLONIDINE HCL 1 PER